| abstract |
The invention relates to an oral entecavir pharmaceutical composition, which comprises 0.4-0.6 of entecavir, 180-200 of a filling agent, 4-6 of a binding agent, 7-9 of a disintegrating agent and 0.5-3 of a lubricating agent, wherein the composition prepared by screening the appropriate filling agent and the binding agent has a good dissolution effect. |